Rizzo M - Search Results

1

The subacute levodopa test for evaluating long-duration response in Parkinson's disease.

Quattrone A, Zappia M, Aguglia U, Branca D, Colao R, Montesanti R, Nicoletti G, Palmieri A, Parlato G, Rizzo M. Quattrone A, et al. Among authors: rizzo m. Ann Neurol. 1995 Sep;38(3):389-95. doi: 10.1002/ana.410380308. Ann Neurol. 1995. PMID: 7668824

2

Long-duration response to levodopa influences the pharmacodynamics of short-duration response in Parkinson's disease.

Zappia M, Colao R, Montesanti R, Rizzo M, Aguglia U, Gambardella A, Oliveri RL, Quattrone A. Zappia M, et al. Among authors: rizzo m. Ann Neurol. 1997 Aug;42(2):245-8. doi: 10.1002/ana.410420217. Ann Neurol. 1997. PMID: 9266736

3

Loss of long-duration response to levodopa over time in PD: implications for wearing-off.

Zappia M, Oliveri RL, Montesanti R, Rizzo M, Bosco D, Plastino M, Crescibene L, Bastone L, Aguglia U, Gambardella A, Quattrone A. Zappia M, et al. Among authors: rizzo m. Neurology. 1999 Mar 10;52(4):763-7. doi: 10.1212/wnl.52.4.763. Neurology. 1999. PMID: 10078724

4

1,4-Benzodiazepine derivatives as anticonvulsant agents in DBA/2 mice.

De Sarro G, Gitto R, Rizzo M, Zappia M, De Sarro A. De Sarro G, et al. Among authors: rizzo m. Gen Pharmacol. 1996 Sep;27(6):935-41. doi: 10.1016/0306-3623(95)02147-7. Gen Pharmacol. 1996. PMID: 8909973

5

Relationship between anticonvulsant activity and plasma level of some 2,3-benzodiazepines in genetically epilepsy-prone rats.

De Sarro G, Rizzo M, Sinopoli VA, Gitto R, De Sarro A, Zappala M, Chimirri A. De Sarro G, et al. Among authors: rizzo m. Pharmacol Biochem Behav. 1998 Nov;61(3):215-20. doi: 10.1016/s0091-3057(98)00036-7. Pharmacol Biochem Behav. 1998. PMID: 9768555

6

Anticonvulsant activity and plasma level of 2,3-benzodiazepin-4-ones (CFMs) in genetically epilepsy-prone rats.

De Sarro G, Rizzo M, Spagnolo C, Gitto R, De Sarro A, Scotto G, Zappala M, Chimirri A. De Sarro G, et al. Among authors: rizzo m. Pharmacol Biochem Behav. 1999 Aug;63(4):621-7. doi: 10.1016/s0091-3057(99)00027-1. Pharmacol Biochem Behav. 1999. PMID: 10462191

7

High-performance liquid chromatographic determination of new 2,3-benzodiazepines.

Rizzo M, Sinopoli VA, Gitto R, Zappalà M, De Sarro G, Chimirri A. Rizzo M, et al. J Chromatogr B Biomed Sci Appl. 1998 Jan 23;705(1):149-53. doi: 10.1016/s0378-4347(97)00463-5. J Chromatogr B Biomed Sci Appl. 1998. PMID: 9498683

8

Determination of 2,3-benzodiazepine derivatives in rat plasma by high-performance liquid chromatography.

Rizzo M, De Sarro G, Gitto R, Zappalà M, Chimirri A. Rizzo M, et al. J Chromatogr A. 1999 Jun 18;846(1-2):165-8. doi: 10.1016/s0021-9673(99)00011-4. J Chromatogr A. 1999. PMID: 10420607

9

Benzodiazepine receptor affinities, behavioral, and anticonvulsant activity of 2-aryl-2,5-dihydropyridazino[4,3-b]indol- 3(3H)-ones in mice.

De Sarro G, Carotti A, Campagna F, Mckernan R, Rizzo M, Falconi U, Palluotto F, Giusti P, Rettore C, De Sarro A. De Sarro G, et al. Among authors: rizzo m. Pharmacol Biochem Behav. 2000 Mar;65(3):475-87. doi: 10.1016/s0091-3057(99)00230-0. Pharmacol Biochem Behav. 2000. PMID: 10683488

10

Structure-activity relationships of 2-aryl-2,5-dihydropyridazino [4,3-b]indol-3(3H)-ones at the benzodiazepine receptor.

Palluotto F, Carotti A, Casini G, Campagna F, Genchi G, Rizzo M, De Sarro GB. Palluotto F, et al. Among authors: rizzo m. Bioorg Med Chem. 1996 Dec;4(12):2091-104. doi: 10.1016/s0968-0896(96)00220-9. Bioorg Med Chem. 1996. PMID: 9022974

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,406 results

Search Page

Filters